Anti-DR4 antibody GTX28414 from GeneTex

Description

GeneTex's Anti-DR4 antibody is a Rabbit Polyclonal antibody. The Anti-DR4 antibody was generated using TNF receptor superfamily member 10a, APO2, CD261, DR4, TRAILR-1, TRAILR1 as the antigen. The Anti-DR4 antibody from GeneTex is a Rabbit Polyclonal antibody to DR4. The Anti-DR4 antibody Recognizes Human, Mouse, Rat. The Anti-DR4 antibody has been validated for the following Applications: WB, ICC/IF, IHC-P, ELISA

Product Specs
ItemAnti-DR4 antibody
CompanyGeneTex
Price $439.00Supplier Page
Catalog NumberGTX28414
Conjugate/TagUnconjugated
FormatPBS, 0.02% Sodium azide
Antibody TypePrimary Antibodies
IsotypeIgG
HostRabbit
ApplicationsWB, ICC/IF, IHC-P, ELISA
TargetDR4
Quantity100 µg
ClonalityPolyclonal
Concentration1mg/ml
ReactivityHu, Ms, Rt
PurityPurified by antigen-affinity chromatography
Research AreaCell Biology
Gene NameTNFRSF10A
Molecular Weight50
NCBI Gene AliasesTNF receptor superfamily member 10a, APO2, CD261, DR4, TRAILR-1, TRAILR1, TRAILR-1, DR4, CD261, APO2, TRAILR1
NCBI Full Gene NameTNF receptor superfamily member 10a
ImmunogenSynthetic peptide, corresponding to amino acids 427-445 of Human DR4

Add to Compare List

GeneTex

GeneTex, Inc. 2456 Alton Parkway

Irvine, California 92606

United States

Phone: 1-877-GeneTex (436-3839) or 949-553-1900
Fax: 949-309-2888

Company Profile

Website: http://www.genetex.com

(1) Virus-infection in cochlear supporting cells induces audiosensory receptor hair cell death by TRAIL-induced necroptosisPloS oneJanuary 1, 2021Hayashi Y, Suzuki H, Nakajima W, Uehara I, Tanimura A, Himeda T, Koike S, Katsuno T, Kitajiri SI, Koyanagi N, et al.rabbit polyclonal anti-cleaved caspase 3 (#9664; 1:100, Cell Signaling), rabbit polyclonal anti-DR4 (GTX28414; 1:1000, GeneTex), rabbit polyclonal anti-DR5 (ab8416; 5 μg/ml, Abcam), and rabbit monoclonal anti-p-Mlkl

(2) MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancerBreast cancer research : BCRFebruary 18, 2019Greer YE, Gilbert SF, Gril B, Narwal R, Peacock Brooks DL, Tice DA, Steeg PS, Lipkowitz S.(LI-COR, Lincoln, NE), using Image Studio software. The following antibodies were used: anti-DR4 (cat#GTX28414, GeneTex, Irvine, CA), anti-DR5 (cat#sc-65314, Santa Cruz, Dallas, TX), and anti-HSC70 (cat#sc-7298,

(3) The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlBreast cancer research and treatmentJanuary 1, 2016Dine JL, O'Sullivan CC, Voeller D, Greer YE, Chavez KJ, Conway CM, Sinclair S, Stone B, Amiri-Kordestani L, Merchant AS, et al.

(4) Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosisLife sciencesApril 1, 2014Ou YC, Li JR, Kuan YH, Raung SL, Wang CC, Hung YY, Pan PH, Lu HC, Chen CJ.

(5) WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosisMolecular cancer research : MCRJanuary 1, 2012Garimella SV, Rocca A, Lipkowitz S.

Be the First to Write a Review!

Anti-DR4 antibody

Anti-DR4 antibody

Anti-DR4 antibody

Anti-DR4 antibody

Anti-DR4 antibody from GeneTex

Description

GeneTex

Citations (5)

Reviews

Anti-DR4 antibody from GeneTex

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map